Medidata Blog

Talking Clinical Trials of the Future with Nina Tandon – EpiBone CEO and TED Senior Fellow and Speaker

Reading Time: < 1 minute

Nina Tandon has been described as a proficient multitasker. After receiving her biomedical engineering PhD from Columbia, she began working at their stem cells and tissue engineering lab on creating a living heart for transplants. She's now the co-founder and CEO of EpiBone, the first company working to grow living human bones for skeletal reconstruction. But that's only the beginning... Nina is also a published author, a TED Senior Fellow and speaker and an adjunct professor of electrical engineering at Cooper Union. Not surprising that she was recently named one of the 40 under 40 people to watch in 2015. And did we mention that she's also a certified yoga instructor and a marathoner? We were fortunate to have Nina as a keynote speaker at our recent Medidata Symposium Europe in Lausanne, Switzerland where she spoke about EpiBone's groundbreaking work as the first and only to grow living human bones. In this first part of our 2-part video interview, Nina talks a little about her work and shares her Symposium takeaways, and how some of the innovations discussed will impact the clinical trials of the future. Watch Part 2 of our video interview with EpiBone CEO Nina Tandon. *Guest blogger Nina Tandon is a co-founder and CEO of EpiBone. You can follow her on Twitter @NinaTandon. You can also follow Nina's company EpiBone @GrowYourOwnBone. TWEET THIS:

VIDEO: Talking #clinicaltrials w/ CEO EpiBone—@GrowYourOwnBone—& @TEDTalks Sr Fellow/Speaker @NinaTandon #MedidataSYM — Medidata (@Medidata) November 25, 2014

Nina Tandon-thumbnail-2

Medidata Solutions Image

Medidata Solutions